Aug 25, 2009 - BioDelivery Sciences International, Inc. today announced the issuance of United States Patent 7,579,019, which will provide additional patent exclusivity for both ONSOLIS™ and BDSI's BEMA® drug delivery technology platform until at least 2019.
The details can be read here.
No comments:
Post a Comment